KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Neogenomics (NEO) Preferred Dividend Payments (2016 - 2018)

Neogenomics filings provide 4 years of Preferred Dividend Payments readings, the most recent being $2.8 million for Q2 2018.

  • On a quarterly basis, Preferred Dividend Payments rose 198.28% to $2.8 million in Q2 2018 year-over-year; TTM through Mar 2019 was $2.8 million, a 49.94% decrease, with the full-year FY2018 number at $5.6 million, down 46.65% from a year prior.
  • Preferred Dividend Payments hit $2.8 million in Q2 2018 for Neogenomics, up from $1.0 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $8.0 million in Q4 2016 to a low of $122000.0 in Q4 2015.
  • Median Preferred Dividend Payments over the past 4 years was $2.7 million (2017), compared with a mean of $3.1 million.
  • Biggest five-year swings in Preferred Dividend Payments: soared 6435.25% in 2016 and later plummeted 83.94% in 2017.
  • Neogenomics' Preferred Dividend Payments stood at $122000.0 in 2015, then soared by 6435.25% to $8.0 million in 2016, then tumbled by 66.25% to $2.7 million in 2017, then grew by 2.97% to $2.8 million in 2018.
  • The last three reported values for Preferred Dividend Payments were $2.8 million (Q2 2018), $1.0 million (Q1 2018), and $2.7 million (Q4 2017) per Business Quant data.